Previous 10 | Next 10 |
David R. Smith, Corporate Executive Vice President & Chief Financial Officer, to Transition Role by End of 2022 Charles River Issues 2022 Financial Guidance in Conjunction with J.P. Morgan Healthcare Conference Charles River Laboratories International, In...
Ariel Investments’ 13F portfolio value increased from $10.64B to $10.94B this quarter. They increased Madison Square Garden Entertainment, Madison Square Garden Sports, and ADT Inc. while decreasing Meredith Corp, Vail Resorts, and Keysight Technologies. The top three posit...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Although the Healthcare sector is having a positive year in absolute terms, that isn't the case in relative terms. Biotech stocks are having a difficult year, in spite of many of those trading at dirt-cheap valuations that don't even reflect the cash they have in-hand. It's very l...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will virtually present at two upcoming investor conferences, including: Jefferies London Healthcare Conference on Thursday, November 18 th , with a pre-recording of the presentation available st...
Charles River Laboratories International, Inc. (NYSE:CRL) today announced that Birgit Girshick has been promoted to the position of Chief Operating Officer, effective immediately. In her most recent role as Corporate Executive Vice President, Ms. Girshick has been responsible for ov...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Image source: The Motley Fool. Charles River Laboratories International, inc (NYSE: CRL) Q3 2021 Earnings Call Nov 5, 2021 , 9:00 a.m. ET Operator Continue reading For further details see: Charles River Laboratories International, inc (CR...
Shares of Charles River Laboratories International (NYSE: CRL) saw its shares plummet 16.7% this week. The stock, which closed last Friday at $448.68, dropped to as low as $373.79 by Thursday. It has been as low as $224.06 and as high as $460.21 the past 52 weeks. Charles River, des...
News, Short Squeeze, Breakout and More Instantly...
Charles River Laboratories International Inc. Company Name:
CRL Stock Symbol:
NYSE Market:
Charles River Laboratories International Inc. Website:
Clinical trials for AAV9 gene therapy bolstered with plasmid and viral vector CDMO expertise Charles River Laboratories International, Inc. (NYSE: CRL) announced today a collaboration with the FOXG1 Research Foundation (FRF) highlighting the patient advocacy group’s model t...
Agreement establishes Charles River as the preferred partner for Autobahn Labs, leveraging drug discovery and development capabilities to accelerate the translation of academic discoveries into novel therapeutics Under the agreement, Charles River will make an equity investment in Aut...
Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2024 financial results on Wednesday, August 7 th , before the market opens. A conference call has been scheduled to discuss this information on Wednesday, August 7 th , at 9:00 a.m. ET. Investors wi...